A study suggests that a surprisingly modest daily walking goal could make a difference for your brain as you age.
Could the geometry of our brains increase the risk of Alzheimer’s disease? It’s a provocative question, but one that some ...
Learn how Alzheimer's disease is diagnosed through history, testing, imaging, and emerging blood biomarkers to support early ...
About one in nine people over 65 have Alzheimer’s — and the number is growing quickly. Without an existing cure, researchers are racing to find ways to prevent and treat the disease, which kills more ...
KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain ...
Agitation associated dementia is one of the most common symptoms of Alzheimer's disease.
The Alzheimer's disease competitive landscape report delivers important insights into approved as well as ongoing research on 240+ pipeline Alzheimer's disease drugs, clinical strategies, upcoming ...
A new study offers hope for those who are at significantly higher risk of developing Alzheimer’s disease later in life.
Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...
In partnership with Eli Lilly and Company, the Suits alum is now raising awareness about early symptomatic Alzheimer's ...
Shanghai Fosun Pharmaceuticals secured regional rights to AR1001 via a $60M option fee. Find out why SFOSF stock is a hold.
The Walk to End Alzheimer’s raises money for research into the disease, while also assisting with outreach and aid to those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results